Table 2.
Characteristic features of included studies | Number | % |
---|---|---|
Total patients | 650 | 100 |
Patients with diabetic retinopathy | 128 | 20 |
Patients with diabetic nephropathy | 90 | 14 |
Patients with metabolic syndrome | 95 | 15 |
Patients with prediabetes | 78 | 12 |
Patients with type 2 diabetes | 259 | 40 |
Coenzyme Q10 supplementation | 323 | 50 |
Placebo | 327 | 50 |